Immunic (IMUX) Other Working Capital Changes (2016 - 2026)
Immunic (IMUX) posted Other Working Capital Changes of -$149000.0 for Q1 2026, up 55.92% sequentially from -$338000.0 in Q4 2025, and down 156.9% YoY from $261878.8 in Q1 2025.
Immunic (IMUX) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Immunic has reported Other Working Capital Changes for 6 years, with the latest figure at -$149000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 156.9% year-over-year to -$149000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$597000.0 (down 348.87% YoY) and the FY2025 annual result came in at -$506000.0, down 96.89% from the prior year.
- Other Working Capital Changes advanced to -$149000.0 in Q1 2026 per IMUX's latest filing, from -$338000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.1 million in Q4 2025 and troughed at -$5.4 million in Q4 2022.
- A 5-year average of -$899411.8 and a median of -$389000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 68.13% in 2025, down 391.38% in 2025.
- Over 3 years, Other Working Capital Changes stood at $116000.0 in 2024, then tumbled by 391.38% to -$338000.0 in 2025, then soared by 55.92% to -$149000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$149000.0, -$338000.0, and -$50000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -208,000.00 |
| Jun 30, 2026 | -208,000.00 |
| Jun 30, 2026 | -208,000.00 |
| Mar 31, 2026 | -149,000.00 |
| Mar 31, 2026 | -149,000.00 |
| Mar 31, 2026 | -149,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Dec 31, 2025 | -338,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -60,000.00 |
| Jun 30, 2025 | -60,000.00 |
| Jun 30, 2025 | -60,000.00 |
| Mar 31, 2025 | -58,000.00 |
| Mar 31, 2025 | -58,000.00 |
| Mar 31, 2025 | -58,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |